NCT06856603View on ClinicalTrials.gov

OLIGO-10: Stereotactic Ablative Radiation Therapy for Metastatic Patients With 6 to 10 Metastatic Sites

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 7, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2030

Conditions
Metastatic Disease
Interventions
RADIATION

stereotactic radiation therapy in ablative doses to each metastatic site

Stereotactic ablative radiation therapy will be utilized for each metastatic site in patients with 6 to 10 sites of metastasis (persistent or progressive disease).

Trial Locations (1)

249033

RECRUITING

A. Tsyb Medical Radiological Research Center, Obninsk

All Listed Sponsors
lead

National Medical Research Radiological Centre of the Ministry of Health of Russia

OTHER